AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

WST · NYSE · Medical - Instruments & Supplies

West Pharmaceutical Services (WST)

Supplies injectable-drug containment, delivery systems, and contract device manufacturing.

$371.09

After hours−0.06 (−0.02%)

At close$371.15(+2.59%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	748	732	695	702	747	749	698	766	804	805	845	872
Cost of revenue	458	453	464	471	482	474	466	493	511	501	549	543
Gross profit	290	279	231	231	265	274	233	273	294	304	296	329
	98	108	104	101	97	104	104	115	120	147	119	150
Research & development	16	18	18	18	16	19	16	19	17	22	16	20
	89	90	87	83	82	85	88	96	103	107	100	118
General & administrative	0	0	0	0	0	0	0	0	0	0	0	118
Other expenses	−7	0	0	0	0	0	0	0	0	19	4	13
Operating income	191	171	127	131	168	171	128	158	174	157	177	179
	0	1	5	2	1	−4	−15	4	0	9	3	1
Interest income	9	9	6	4	5	5	4	4	5	5	3	1
Interest expense	3	1	2	2	1	0	0	0	0	0	0	0
Other non-operating income	1	1	−2	1	3	6	18	1	0	−6	3	0
Income before tax	191	172	132	133	168	167	114	162	174	165	180	180
Income tax expense	29	35	16	22	32	37	24	30	34	33	45	32
Net income from continuing operations	161	137	115	111	136	130	90	132	140	132	135	148
Other adjustments	0	0	0	0	0	0	0	0	0	0	3	6
Net income	161	137	115	111	136	130	90	132	140	132	139	154
EPS, basic	$2.17	$1.85	$1.57	$1.52	$1.87	$1.79	$1.24	$1.82	$1.94	$1.83	$1.93	$2.17
EPS, diluted	$2.14	$1.83	$1.55	$1.51	$1.85	$1.78	$1.23	$1.82	$1.93	$1.82	$1.92	$2.15
Weighted average shares, basic	74	74	74	73	73	73	73	72	72	72	72	71
Weighted average shares, diluted	75	75	74	74	73	74	73	73	73	73	72	71
EBITDA	226	205	165	169	205	206	151	199	217	210	219	179
Depreciation & amortization	36	36	36	39	40	41	40	41	43	47	45	0
EBIT	190	169	129	130	165	165	111	157	174	163	174	179